Iron Oxide Nanoparticles Functionalized with Macrocycle Antagonists for CXCR4 Receptor Targeting in Cancer Cells. J. Anal. Oncol. [Internet]. 2024 Dec. 4 [cited 2025 Oct. 21];13:36-42. Available from: https://mail.neoplasiaresearch.com/index.php/jao/article/view/794